10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Risk of cancer progression is reduced for patients with human papillomavirus (HPV) -positive oropharynx cancer (OPC) relative to HPV-negative OPC, but it is unknown whether risk of death after progression is similarly reduced.

          Related collections

          Author and article information

          Journal
          J. Clin. Oncol.
          Journal of clinical oncology : official journal of the American Society of Clinical Oncology
          1527-7755
          0732-183X
          Oct 20 2014
          : 32
          : 30
          Affiliations
          [1 ] Carole Fakhry, Johns Hopkins Medical Institutions; Milton J. Dance Jr Head and Neck Center, Baltimore, MD; Qiang Zhang, Jonathan Harris, Radiation Therapy Oncology Group Statistical Center; John Andrew Ridge, Fox Chase Cancer Center, Philadelphia, PA; David Rosenthal, Adel El-Naggar, Adam S. Garden, The University of Texas MD Anderson Cancer Center, Houston, TX; Andy Trotti, H. Lee Moffitt Cancer Center, Tampa, FL; Vilija Avizonis, Intermountain Medical Center, Murray, UT; Quynh-Thu Le, Stanford University Medical Center, Stanford, CA; Maura Gillison, Ohio State University Medical Center, Columbus, OH; Phuc Felix Nguyen-Tan, Denis Soulieres, Centre Hospitalier de l'Université de Montréal Hospital Notre Dame, Montreal, Canada. cfakhry@jhmi.edu.
          [2 ] Carole Fakhry, Johns Hopkins Medical Institutions; Milton J. Dance Jr Head and Neck Center, Baltimore, MD; Qiang Zhang, Jonathan Harris, Radiation Therapy Oncology Group Statistical Center; John Andrew Ridge, Fox Chase Cancer Center, Philadelphia, PA; David Rosenthal, Adel El-Naggar, Adam S. Garden, The University of Texas MD Anderson Cancer Center, Houston, TX; Andy Trotti, H. Lee Moffitt Cancer Center, Tampa, FL; Vilija Avizonis, Intermountain Medical Center, Murray, UT; Quynh-Thu Le, Stanford University Medical Center, Stanford, CA; Maura Gillison, Ohio State University Medical Center, Columbus, OH; Phuc Felix Nguyen-Tan, Denis Soulieres, Centre Hospitalier de l'Université de Montréal Hospital Notre Dame, Montreal, Canada.
          Article
          JCO.2014.55.1937
          10.1200/JCO.2014.55.1937
          24958820
          afcad9a7-d76f-4a61-8372-5c53d33a468f
          © 2014 by American Society of Clinical Oncology.
          History

          Comments

          Comment on this article